Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
Merck,Pfizer,eisai
['renal,(-adrenal)', 'pembro', 'lenva']
lenvatinib/pembrolizumab efficacy in renal cell carcinoma sustained at 4-year follow-up #asco23 #urology #urologist #kidneycancer 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.